Zaragoza, España
Propósito: La neuropatía periférica inducida por quimioterapia (NPIQ) es un efecto secundario común y limitante de la dosis de citostático. Se ha observado que la prevalencia de la NPIQ en pacientes con tratamiento con medicamentos derivados de los platinos es muy alta. Dado que no se han probado procedimientos terapéuticos contra la NPIQ, estamos interesados en definir el rol que cumple la electroacupuntura (EA), y los datos preliminares han mostrado resultados prometedores.
Métodos: En un estudio aleatorio con un diseño adaptable para grupo secuencial en pacientes con NPIQ, comparamos EA (LV3, SP9, GB41, Gb34, LI4, LI11, SI3, y HT3;) con el tratamiento de placebo. La potencia estadística en este ensayo se calculó para comparar los resultados de los tratamientos con EA con los tratamientos placebo.
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and dose- limiting side effect from cytostatic drugs, and, it has been observed that the prevalence of peripheral neuropathy in patients with treatments that involve platinum derivatives drugs is very high. Since there have been no proven therapeutic procedures against CIPN, we were interested in defining the role of electroacupuncture (EA) from which preliminary data has shown promising results.
Methods: In a randomized trial with a group sequential adaptive design in patients with CIPN, we compared EA (LV3, SP9, GB41, GB34, LI4, LI11, SI3, and HT3; ) with placebo treatment. The statistical power in this trial was primarily calculated to prove EA only and compare the results we’ll have about the patients that have had EA with the ones that have had placebo treatment.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados